Compare
Cagrilintide vs Eloralintide
The honest difference
Both are experimental weekly injections that copy amylin, the fullness hormone. Cagrilintide has a large year-long study; eloralintide has one mid-size study so far.
Peptide
Cagrilintide
Grade B: promising human evidence
Why people buy it
People take it to lose weight. It is a new weekly injection that makes you feel full.
Bottom line
Strong early results in people, but not yet approved. The online versions are not the real thing.
- UK status
- Investigational drug, not a licensed UK medicine. The MHRA has not granted cagrilintide a marketing authorisation, it is not available on prescription or via the NHS, and the CagriSema combination is at most under regulatory review.
- Sport / WADA
- Prohibited at all times under S0 (non-approved substances). The WADA 2026 Prohibited List bans any substance not covered by another section that has no current approval by any government health authority for human therapeutic use, explicitly including drugs in clinical development.
Peptide
Eloralintide
Grade B: promising human evidence
Why people buy it
People buy it to lose weight. It is a new weekly injection that makes you feel full.
Bottom line
Promising early results in people, but only from one mid-size study. The online versions are not the tested product.
- UK status
- Investigational drug, not a licensed UK medicine. The MHRA has not granted a marketing authorisation, and it is not available on prescription or the NHS.
- Sport / WADA
- Prohibited at all times under S0 (non-approved substances). The WADA 2026 Prohibited List bans any substance with no current approval by a regulatory health authority for human therapeutic use, explicitly including drugs in clinical development.
Grades are about evidence in humans, not about whether something is right for you. Nothing here is dosing advice. Talk to a qualified clinician before any health decision.
More comparisons